New hope for hemophilia: Long-Acting drug shows promise in chinese trial
NCT ID NCT05082116
First seen Jan 08, 2026 · Last updated Jun 19, 2026 · Updated 23 times
Summary
This study tested a medicine called turoctocog alfa pegol (N8-GP) in 36 Chinese men with severe hemophilia A, a bleeding disorder. The drug helps blood clot and was given as an injection to prevent or stop bleeding episodes. The trial lasted about 7-8 months and measured how many bleeds occurred per year and how well the drug controlled bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Children's Hospital, Capital Medical University
Beijing, Beijing Municipality, 100045, China
-
Fujian Medical University Union Hospital-Hematology
Fuzhou, Fujian, 350001, China
-
Institute of Hematology and Blood Diseases Hospital, Tianjin-Hematology
Tianjin, Tianjin Municipality, 300020, China
-
Institute of hematology and Blood Diseases Hospital, Tianjin
Tianjin, Tianjin Municipality, 300020, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Nanfang Hospital, Southern Medical University-Haematology
Guangzhou, Guangdong, 510515, China
-
Qinghai Provincial People's Hospital
Xining, Qinghai, 810007, China
-
The Affiliated Hospital of Guizhou Medical University-Hematology
Guiyang, Guizhou, 550004, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650101, China
-
Xiangya Hospital Central-South University
Changsha, Hunan, 410008, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.